Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft earned expanded FDA clearance for lumbar degenerative disc disease in adults.
The new clearance means PearlMatrix is the only Class III drug-device spinal bone graft approved for all major lumbar interbody surgical approaches, according to a Jan. 13 news release. It has indications for one-level ALIF, PLIF, OLIF, LLIF and TLIF.
PearlMatrix is also approved for use with itanium alloy and PEEK/titanium interbody fusion cages cleared by the FDA.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
